Advancing Women’s Cardiovascular Health
Non-invasive cardiovascular assessment across the female life span
Cardiovascular assessment from pregnancy to menopause


Seeing beyond conventional blood pressure
1 in 5 pregnancies is affected by hypertensive disorders globally. ~8% develop preeclampsia, a leading cause of maternal mortality and morbidity. Women who experience it carry a 72% higher lifetime cardiovascular risk.
Yet today, 50% of preeclampsia cases are missed before term. Pregnancy acts as a cardiovascular stress test. Hypertensive disorders are early markers of systemic CVD risk, not just pregnancy complications.
Understand Maternal Hemodynamics in Pregnancy
Pregnancy requires major cardiovascular adaptation. Non-invasive pulse wave analysis provides insight into cardiac output, vascular resistance, central blood pressure and other cardiovascular parameters, helping clinicians characterize maternal hemodynamic profiles beyond conventional blood pressure measurement.

Investigating Hemodynamic Markers of Preeclampsia Risk
Preeclampsia is closely linked to abnormal maternal vascular adaptation. Evaluating hemodynamic and vascular biomarkers for earlier risk assessment. The PERI Score is under development to investigate associations between these signals and maternal cardiovascular risk.

Supporting Research toward Personalized Cardiovascular Care
Women's cardiovascular risk evolves across the life course. Our research platform combines validated cardiovascular measurements with investigational digital biomarkers to explore individualized cardiovascular profiling.
